Sign inJoin waitlistJoin the waitlist

DG

Devika Gajria

Medical Site Director, MSK Bergen · New York Presbyterian Hospital

Credentials: · · ·

History

Memorial Sloan Kettering Bergen
2024–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2008–2011
Internal Medicine
University of Chicago Medical Center
2005–2008
Feinberg School of Medicine
2001–2005

Research

HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
Review · Expert Review of Anticancer Therapy · 2011 · First of 2 authors · 368 citations
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors
Breast Cancer Research · 2013 · 90 citations
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer
JAMA Dermatology · 2018 · 81 citations

CH
Clifford Hudis
6 papers
LN
Larry Norton
6 papers
TT
Tiffany Traina
6 papers
CD
Chau Dang
5 papers
MT
Maria Theodoulou
5 papers
Mario Lacouture
5 papers
SM
Shanu Modi
5 papers
SG
Shari Goldfarb
5 papers
DL
Diana Lake
4 papers
GD
Gabriella D'Andrea
4 papers
MF
Monica Fornier
4 papers
AM
Alina Markova
3 papers

Clinical trials

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery
Principal investigator · Terminated · Phase 1
National Cancer Institute (NCI)
2012